Tag: Biotechnology

ROSLINCT
Europe

RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer

October 03, 2023 08:00 AM Eastern Daylight Time EDINBURGH, Scotland & BOSTON – RoslinCT, a leading contract development and manufacturing organization (CDMO) for Advanced Cell and Gene Therapies, is pleased to announce the appointment of Dean J. Morris as the Chief Operations Officer at their Boston facility. Mr. Morris brings a wealth of experience and expertise in commercial manufacturing operations, process development, engineering, validation, and … Continue reading RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer

Impact Newswire
SONOMA BIOTHERAPEUTICS
Global, United States

Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer

Co-founder Fred Ramsdell, Ph.D., to retire from Chief Scientific Officer position September 29, 2023 07:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif. & SEATTLE – Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the appointments of Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, … Continue reading Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer

Impact Newswire
Ligand
Global, United States

Ligand Appoints Martine Zimmermann to its Board of Directors

September 26, 2023 05:05 PM Eastern Daylight Time SAN DIEGO – Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced the appointment of Martine Zimmermann, PharmD, to its Board of Directors as an independent director. Dr. Zimmermann brings 25 years of global experience in the pharmaceutical industry to Ligand’s board. “We are very pleased to welcome Martine to our board of directors. She brings considerable expertise in development and … Continue reading Ligand Appoints Martine Zimmermann to its Board of Directors

Impact Newswire
BROKEN STRING BIOSCIENCES
Global, Untied Kingdom

Broken String Biosciences Closes $15M Series A Funding Round

– Funds to support further development and commercialization of the Company’s INDUCE-seq DNA break mapping technology – Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression of cell and gene therapy programs – New investors include Illumina Ventures, Mérieux Equity Partners, and HERAN Partners September 18, 2023 04:17 AM Eastern Daylight Time CAMBRIDGE, England–(BUSINESS WIRE)–Broken String Biosciences (“Broken String”), a genomics … Continue reading Broken String Biosciences Closes $15M Series A Funding Round

Impact Newswire
ImmunoGen
Global, United States

ImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial Officer

September 18, 2023 06:30 AM Eastern Daylight Time WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Lauren White has been appointed Senior Vice President and Chief Financial Officer. “We are excited to have Lauren join our team and believe that her expertise in financial planning and strategy, operations, and investor … Continue reading ImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial Officer

Impact Newswire
RENAGADE THERAPEUTICS
Global, United States

ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer

Former CFO of Mirati and Arena to join ReNAgade Therapeutics Strengthens leadership team, bringing vast experience leading the finance function of high-growth companies September 12, 2023 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as Chief Financial Officer of Mirati … Continue reading ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer

Impact Newswire
Matica Biotechnology, Inc.
Global, United States

Matica Bio Appoints Life Sciences Veterans Laura Parks, Heather N. Sugrue to Top Leadership Positions

September 14, 2023 09:00 AM Eastern Daylight Time COLLEGE STATION, Texas–(BUSINESS WIRE)–Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the GMP production of cell and gene therapies (CGT), today announced the appointment of Laura Parks as executive vice president of Commercial Operations and Heather N. Sugrue as vice president of Alliance Management. “I’m excited to join Matica Bio’s team of … Continue reading Matica Bio Appoints Life Sciences Veterans Laura Parks, Heather N. Sugrue to Top Leadership Positions

Impact Newswire
DNANEXUS
Global, United States

DNAnexus Announces Appointment of Thomas Laur as CEO

Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors September 12, 2023 09:02 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and … Continue reading DNAnexus Announces Appointment of Thomas Laur as CEO

Impact Newswire